LianBio (LIAN) Competitors $0.38 +0.01 (+2.01%) As of 05/20/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendInsider TradesSEC FilingsTrendsBuy This Stock LIAN vs. TIL, GALT, ZURA, TELO, GNTA, ADAG, SNTI, OCX, IZTC, and CLLSShould you be buying LianBio stock or one of its competitors? The main competitors of LianBio include Instil Bio (TIL), Galectin Therapeutics (GALT), Zura Bio (ZURA), Telomir Pharmaceuticals (TELO), Genenta Science (GNTA), Adagene (ADAG), Senti Biosciences (SNTI), OncoCyte (OCX), Invizyne Technologies (IZTC), and Cellectis (CLLS). These companies are all part of the "pharmaceutical products" industry. LianBio vs. Instil Bio Galectin Therapeutics Zura Bio Telomir Pharmaceuticals Genenta Science Adagene Senti Biosciences OncoCyte Invizyne Technologies Cellectis LianBio (NASDAQ:LIAN) and Instil Bio (NASDAQ:TIL) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, community ranking, earnings, dividends, media sentiment, risk and analyst recommendations. Does the media prefer LIAN or TIL? In the previous week, LianBio's average media sentiment score of 0.00 equaled Instil Bio'saverage media sentiment score. Company Overall Sentiment LianBio Neutral Instil Bio Neutral Is LIAN or TIL more profitable? LianBio's return on equity of -33.17% beat Instil Bio's return on equity.Company Net Margins Return on Equity Return on Assets LianBioN/A -33.17% -30.19% Instil Bio N/A -37.44%-25.08% Which has more volatility and risk, LIAN or TIL? LianBio has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Comparatively, Instil Bio has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500. Do analysts rate LIAN or TIL? Instil Bio has a consensus price target of $114.00, suggesting a potential upside of 602.84%. Given Instil Bio's stronger consensus rating and higher possible upside, analysts clearly believe Instil Bio is more favorable than LianBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LianBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Instil Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the MarketBeat Community prefer LIAN or TIL? Instil Bio received 98 more outperform votes than LianBio when rated by MarketBeat users. Likewise, 50.25% of users gave Instil Bio an outperform vote while only 36.36% of users gave LianBio an outperform vote. CompanyUnderperformOutperformLianBioOutperform Votes436.36% Underperform Votes763.64% Instil BioOutperform Votes10250.25% Underperform Votes10149.75% Do insiders & institutionals have more ownership in LIAN or TIL? 74.8% of LianBio shares are owned by institutional investors. Comparatively, 60.6% of Instil Bio shares are owned by institutional investors. 7.6% of LianBio shares are owned by insiders. Comparatively, 47.2% of Instil Bio shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has stronger earnings & valuation, LIAN or TIL? Instil Bio is trading at a lower price-to-earnings ratio than LianBio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianBioN/AN/A-$110.29M-$0.81-0.47Instil BioN/AN/A-$156.09M-$11.97-1.36 SummaryInstil Bio beats LianBio on 9 of the 14 factors compared between the two stocks. Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIAN vs. The Competition Export to ExcelMetricLianBioBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$41.06M$129.31M$5.37B$8.39BDividend YieldN/A3.74%5.22%4.10%P/E Ratio-0.473.4426.7719.71Price / SalesN/A4,251.39393.17117.39Price / CashN/A13.1938.2534.62Price / Book0.1433.126.794.50Net Income-$110.29M-$91.56M$3.23B$248.18M7 Day Performance90.10%3.25%1.53%0.20%1 Month Performance90.00%8.05%10.06%12.37%1 Year Performance21.33%101.86%16.74%7.04% LianBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIANLianBioN/A$0.38+2.0%N/A+21.3%$41.06MN/A-0.47110Gap DownTILInstil Bio2.2194 of 5 stars$12.74-6.9%$114.00+794.8%+45.2%$83.56MN/A-1.10410Gap DownGALTGalectin Therapeutics1.2204 of 5 stars$1.32-5.0%$11.00+733.3%-60.4%$83.40MN/A-1.819Earnings ReportGap UpZURAZura Bio2.859 of 5 stars$1.21-2.4%$14.33+1,084.6%-81.3%$82.73MN/A-1.733News CoverageAnalyst RevisionGap UpTELOTelomir Pharmaceuticals1.7156 of 5 stars$2.75+9.6%$15.00+445.5%-62.6%$81.85MN/A-4.741News CoverageGNTAGenenta Science1.4964 of 5 stars$4.45+7.0%$25.00+461.8%+38.7%$81.39MN/A0.007Gap DownADAGAdagene2.3111 of 5 stars$1.72+1.2%$8.00+365.1%-35.9%$81.03M$103,204.000.00260Positive NewsGap UpSNTISenti Biosciences1.6894 of 5 stars$3.10-4.9%$12.00+287.1%-14.7%$80.85M$2.56M-0.204OCXOncoCyte2.414 of 5 stars$2.77-1.4%$4.42+59.4%+8.9%$79.22M$1.88M-0.63120Analyst ForecastGap DownIZTCInvizyne TechnologiesN/A$12.54-3.6%N/AN/A$78.40MN/A0.00N/ACLLSCellectis2.7594 of 5 stars$1.41-6.6%$6.67+372.8%-48.5%$78.37M$41.51M-1.08290 Related Companies and Tools Related Companies TIL Alternatives GALT Alternatives ZURA Alternatives TELO Alternatives GNTA Alternatives ADAG Alternatives SNTI Alternatives OCX Alternatives IZTC Alternatives CLLS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIAN) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Share LianBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LIAN Stock Free LIAN Stock Alerts